Learn More
CERILLIANT™ XLR-11 4-Hydroxypentyl metabolite Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco S0801ML
Description
A primary urinary metabolite of XLR-11, a popular third generation synthetic cannabinoid that purportedly can cause serious adverse health effects including kidney damage and stroke. XLR-11 is similar in structure to UR-144 and A-796,260, two compounds originally developed as pharmaceutical drug candidates due to their high affinity for the cannabinoid receptor CB2. Our certified synthetic cannabinoid solution standards are DEA-exempt, allowing laboratories to order these standards without DEA paperwork.
Specifications
| 67-56-1 | |
| UN 1230 - class 3 - PG 2 - Methanol, solution | |
| 345.45 | |
| 1 mL |
| C21H28FNO2 | |
| 100 μg/mL in methanol | |
| Ampule |
Safety and Handling
H331-H370
H311
Recommended Storage : -20°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
CERILLIANT is a registered trademark of Cerilliant Corporation